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Abstract
Background: E-cadherin, a cell surface protein involved in cell adhesion, is present in normal
breast epithelium, benign breast lesions, and in breast carcinoma. Alterations in the gene CDH1 on
chromosome 16q22 are associated with changes in E-cadherin protein expression and function.
Inactivation of E-cadherin in lobular carcinomas and certain diffuse gastric carcinomas may play a
role in the dispersed, discohesive "single cell" growth patterns seen in these tumors. The molecular
"signature" of mammary lobular carcinomas is the loss of E-cadherin protein expression as
evidenced by immunohistochemistry, whereas ductal carcinomas are typically E-cadherin positive.
Patients and methods: We report on E-cadherin immunostaining patterns in five cases of
invasive mammary carcinoma
Results: These were five exceptional instances in which the E-cadherin immunophenotype did not
correspond to the apparent histologic classification of the lesion. These cases which are
exceedingly rare in our experience are the subject of this report.
Conclusion:  Findings such as those illustrated in this study occur in virtually all biologic
phenomena and they do not invalidate the very high degree of correlation between the expression
of E-cadherin and the classification of breast carcinomas as ductal or lobular type on the basis of
conventional histologic criteria.
Background
The utility of the E-cadherin immunohistochemical stain
to distinguish between lobular and ductal carcinomas that
are difficult to classify by morphologic features alone has
been well-documented in recent years [1-8]. However,
greater experience in the staining patterns of lobular and
ductal lesions with the E-cadherin stain has led to the dis-
covery of rare instances of unexpected E-cadherin staining
[1,6,7,9]. In this study, we report 5 cases of invasive mam-
mary carcinoma with a striking discordance between the
structural phenotype of the lesion in hematoxylin and
eosin sections and immunohistochemical staining pat-
tern for E-cadherin, a phenomenon we have termed as
"aberrant".
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Patients and methods
Four cases were obtained from the Pathology department
of the New York Presbyterian Hospital-Weill Medical Col-
lege of Cornell University and a fifth case from Memorial
Sloan Kettering Cancer Center, between Jan 1999 and July
2004. All specimens were available as formalin-fixed par-
affin embedded tissue blocks and hematoxylin and eosin
stained slides.
For E-cadherin immunostaining, four micron-thick sec-
tions were prepared from paraffin blocks containing
lesional tissue. The slides were subsequently deparaffin-
ized in three 5-minute changes of xylene and rehydrated
through graded alcohols to distilled water. Heat induced
epitope retrieval was performed on paraffin sections by
pretreatment in a pressure cooker using 10 mM citrate
buffer pH 6.0 for two minutes. Immunohistochemical
staining was performed on paraffin sections using a Tech-
Mate 500 TM automated immunostainer (Ventana Medi-
cal Systems, Inc., Tuscon, AX) according to a modified
MIP protocol (Ventana Medical System, Inc.) using the
ChemMate ABC peroxidase secondary detection system
(Ventana Medical Systems, Inc). A monoclonal antibody
to E-cadherin, clone HECD-1 (Zymed Laboratories, Inc.,
San Francisco, CA) was used in 1:400 dilution. The perox-
idase reaction was developed using DAB chromogen pro-
vided in the kit. Sections were counterstained with
hematoxylin. The hematoxylin and eosin and immuno-
histochemical stained slides were subsequently reviewed
and histopathologic features of lesional areas recorded.
Results
A summary of the morphologic and immunohistochemi-
cal features of the following five cases is presented in Table
1.
Case 1
A 62 year-old woman underwent a left lumpectomy in
April of 2001 which revealed invasive carcinoma, histo-
logically classified as ductal type.
Microscopic findings
The 2.3 cm invasive carcinoma was well to moderately dif-
ferentiated with intermediate nuclear grade. Well-formed
ducts comprised greater than 90% of the invasive carci-
noma (Figure 1A). In some areas, tumor cells assumed a
linear growth pattern and contained intracytoplasmic
mucin vacuoles (Figure 1A, inset). The invasive carcinoma
was estrogen and progesterone receptor positive by
immunohistochemistry. Lobular carcinoma in-situ
(LCIS), mostly of the classical type with some foci having
pleomorphic features and apocrine cytology was also
present. In areas, classical LCIS extended into adjacent
ducts in a pagetoid distribution. A single axillary lymph
node was involved by metastatic carcinoma composed of
tumor cells in a diffuse, discohesive pattern characteristic
of metastatic lobular carcinoma. Focal gland formation
was also evident in this metastatic deposit. Intracytoplas-
mic mucin vacuoles were readily identified within tumor
cells.
An E-cadherin immunohistochemical stain was per-
formed on representative samples of invasive, in-situ, and
metastatic carcinoma. No cell membrane reactivity was
demonstrated in the primary invasive carcinoma or in the
nodal metastasis including areas of glandular differentia-
tion (Figure 1B and 1C). Complete absence of E-cadherin
immunoreactivity was also seen in foci of LCIS.
In this case, aberrant E-cadherin protein expression was
represented by absence of cell membrane immunoreactiv-
ity in gland-forming regions of invasive as well as meta-
static carcinoma which appeared to be phenotypically
"ductal".
Case 2
A 60 year-old female presented with a left breast mass.
Subsequent excisional biopsy revealed invasive duct carci-
noma.
Table 1: Histologic classification and "aberrant" E-cadherin staining patterns in invasive mammary carcinomas.
Case In-situ E-cadherin Invasive E-cadherin Metastasis E-cadherin
1 Lobular Negative Ductal Negative Lobular Negative
2 Ductal Pos, ++ Ductal Pos, + Lobular Pos, +++
Lobular Negative
3 Lobular Negative Ductal Pos, + CK-pos Not Done
Ductal Negative
4 Lobular Not Done Lobular Pos, +++* Lobular Pos, +++
5 Lobular                       Negative                       Lobular                       Negative                       None                      
*in pleomorphic areas. Weak, discontinuous positivity was seen in more classical areas of invasive carcinoma in the same tumor.
Pos-positive; + weak, ++ moderate, and +++ strong cell membrane immunoreactivity.World Journal of Surgical Oncology 2005, 3:73 http://www.wjso.com/content/3/1/73
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Microscopic findings
The lumpectomy specimen contained an 8 mm invasive
well-differentiated duct carcinoma. Although greater than
90% of the tumor exhibited glandular differentiation,
very focal areas with a single cell and linear growth pattern
were also present (Figure 2A). The invasive carcinoma was
estrogen and progesterone receptor positive and negative
for HER-2/neu protein overexpression by immunohisto-
chemistry. In-situ carcinoma was ductal in type with cri-
briform architecture and low nuclear grade arising
predominantly in a background of typical and atypical
columnar cell hyperplasia. Classical LCIS that expanded
lobules with central discohesion was also present. The re-
excisional specimen revealed additional foci of LCIS and
no invasive carcinoma. An ipsilateral sentinel lymph node
biopsy was performed. The lymph node was involved by
metastatic carcinoma with a diffuse, discohesive growth
pattern characteristic of lobular carcinoma. A minority of
the tumor (<5%) also showed glandular differentiation.
The immunohistochemical stain for E-cadherin showed
weak cell membrane reactivity in areas of the primary
invasive carcinoma exhibiting a ductal phenotype (Figure
2A). In contrast, areas of invasive carcinoma with a linear,
"lobular" phenotype displayed strong, uniform cell mem-
brane staining (not shown). Diffuse, strong and uniform
immunoreactivity was also seen in the nodal metastasis
(Figure 2B).
Foci of intraductal carcinoma demonstrated moderate
positivity for E-cadherin while those of classical LCIS were
negative for this antigen.
Absence of E-cadherin in invasive "ductal" carcinoma (case 1) Figure 1
Absence of E-cadherin in invasive "ductal" carcinoma (case 1). A: Moderately differentiated invasive ductal carcinoma. Focally, 
tumor cells are seen growing in a linear fashion and contain intracytoplasmic mucin vacuoles (inset) (Hematoxylin and eosin). 
B: Invasive ductal carcinoma exhibiting complete absence of reactivity for E-cadherin. Normal duct serves as an internal posi-
tive control (Immunoperoxidase stain for E-cadherin). C: Metastatic carcinoma with glandular differentiation (Hematoxylin and 
eosin, left) showing complete absence of E-cadherin immunoreactivity (Immunoperoxidase stain for E-cadherin, right).World Journal of Surgical Oncology 2005, 3:73 http://www.wjso.com/content/3/1/73
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In this case, aberrant E-cadherin protein expression con-
sisted of weak immunoreactivity in the "ductal" areas of
invasive carcinoma, whereas strong positivity was appreci-
ated in areas of invasive and metastatic carcinoma with a
lobular histologic phenotype.
Case 3
A 62 year-old woman presented with a right breast mass.
Stereotactic needle core biopsy revealed an invasive, mod-
erately differentiated carcinoma that was classified as duc-
tal. Subsequent wide local excision included the needle
core biopsy site as well as an area of radiographic density
not previously sampled.
Microscopic findings
The excisional biopsy revealed two separate invasive
tumors measuring 8 and 5 mm, respectively. Well-formed
glands comprised 80–90% of both tumors. Adjacent clas-
sical LCIS was also present. The larger tumor was strongly
positive for estrogen and progesterone receptors by
immunohistochemistry. No membrane expression for
HER-2/neu was appreciated. A single ipsilateral sentinel
lymph node contained several cytokeratin-positive cells.
Five additional axillary lymph nodes were free of meta-
static disease.
E-cadherin reactivity in metastatic "lobular" carcinoma (case 2) Figure 2
E-cadherin reactivity in metastatic "lobular" carcinoma (case 2). A: Well-differentiated invasive ductal carcinoma (Hematoxylin 
and eosin, left) exhibiting weak cell membrane positivity for E-cadherin (Immunoperoxidase stain for E-cadherin, right). B: 
Nodal metastasis demonstrating strong cell membrane immunoreactivity for E-cadherin; higher magnification of tumor cells 
(inset) (Immunoperoxidase stain for E-cadherin).
Weak and absent E-cadherin reactivity in two concurrent invasive "ductal" carcinomas (case 3) Figure 3
Weak and absent E-cadherin reactivity in two concurrent invasive "ductal" carcinomas (case 3). A: Larger invasive ductal carci-
noma exhibiting weak staining for E-cadherin. Normal duct serves as an internal positive control (Immunoperoxidase stain for 
E-cadherin). B: Smaller invasive ductal carcinoma showing complete absence of staining for E-cadherin. Normal duct serves as 
an internal positive control (Immunoperoxidase stain for E-cadherin).World Journal of Surgical Oncology 2005, 3:73 http://www.wjso.com/content/3/1/73
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The immunohistochemical stain for E-cadherin of the
larger tumor was weak and discontinuous (Figure 3A).
There was no E-cadherin cell membrane reactivity in the
smaller invasive carcinoma (Figure 3B) or in adjacent
LCIS (not shown). An E-cadherin stain was not performed
on the sentinel lymph node.
Aberrant E-cadherin protein expression in this case con-
sisted of predominantly negative immunoreactivity in
invasive tumors exhibiting a ductal histological pheno-
type.
Case 4
A 57 year-old woman presented with a mass in the left
breast.
Microscopic findings
The excised specimen contained a 2.9 cm invasive and in-
situ poorly differentiated carcinoma. More than 90% of
the tumor consisted of invasive carcinoma which exhib-
ited predominantly alveolar and solid growth patterns,
absence of gland formation, and intermediate-high
nuclear grade (Figure 4A, left). In-situ carcinoma com-
prised the remainder of the tumor mass and had a solid
growth pattern, apocrine features, and intermediate-high
nuclear grade. Both invasive and in-situ carcinoma
formed signet-ring cells containing bluish-tinged, intracy-
toplasmic mucin vacuoles and together with the nuclear
atypia, had the appearance of pleomorphic lobular carci-
noma. The invasive carcinoma showed nuclear reactivity
for estrogen and progesterone receptors by immunohisto-
E-cadherin reactivity in invasive "lobular" carcinoma (case 4) Figure 4
E-cadherin reactivity in invasive "lobular" carcinoma (case 4). A: Invasive carcinoma with pleomorphic lobular features showing 
predominantly alveolar and solid growth patterns and intermediate-high nuclear grade (Hematoxylin and eosin, left). Strong cell 
membrane E-cadherin reactivity in tumor cells and in normal adjacent ductal epithelium (Immunoperoxidase for E-cadherin, 
right). B: Some tumor cells demonstrate a punctate staining pattern within the cell membrane or in the cytoplasm (Immu-
noperoxidase for E-cadherin). C: Metastatic carcinoma with lobular characteristics involving an ipsilateral axillary lymph node 
(Hematoxylin and eosin, left). Tumor cells showing strong cell membrane reactivity for E-cadherin (Immunoperoxidase for E-
cadherin, right).World Journal of Surgical Oncology 2005, 3:73 http://www.wjso.com/content/3/1/73
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chemistry. The subsequent left mastectomy specimen
revealed residual invasive carcinoma. A single, 2.2 cm left
axillary lymph node contained metastatic carcinoma with
extranodal extension. Morphologically, the metastatic
deposit showed a "lobular phenotype" in the form of sig-
net-ring cells growing in a diffuse distribution and
absence of glandular differentiation (Figure 4C, left).
An E-cadherin immunohistochemical stain performed on
the primary invasive carcinoma revealed a heterogeneous
staining pattern. Tumor areas with alveolar and solid
growth patterns exhibited strong, continuous cell mem-
brane immunoreactivity (Figure 4A, right) while those
having a linear growth pattern had relatively weaker, dis-
continuous positivity (not shown). Additionally, some
tumor cells demonstrated a punctate staining pattern
either within the cell membrane or cytoplasm (Figure 4B).
Overall, the E-cadherin reactivity was interpreted as posi-
tive in areas of invasive carcinoma despite heterogeneous
staining in some areas. Metastatic carcinoma involving
the lymph node demonstrated strong, continuous mem-
brane staining (Figure 4C, right).
Aberrant staining in this case consisted of strong E-cad-
herin protein expression in areas of primary invasive car-
cinoma morphologically resembling pleomorphic
lobular carcinoma. Weaker, discontinuous E-cadherin
positivity was observed in other areas of the invasive car-
cinoma resembling classical type of lobular carcinoma.
Punctate membrane or cytoplasmic staining by E-cad-
herin was also observed in some tumor cells. The lymph
node metastasis which also had a "lobular" appearance
had strong membrane E-cadherin reactivity similar to that
seen in the primary invasive carcinoma.
Invasive lobular carcinoma with glandular "ductal" differentiation (case 5) Figure 5
Invasive lobular carcinoma with glandular "ductal" differentiation (case 5). A: Moderately differentiated invasive "ductal" carci-
noma and carcinoma in situ on core biopsy (Hematoxylin and eosin, right) showing complete absence of E-cadherin immunore-
activity. (Immunoperoxidase stain for E-cadherin, left). B: No immunoreactivity for E-cadherin (Immunoperoxidase stain for E-
cadherin, left) confirms invasive lobular carcinoma with glandular differentiation in the excision biopsy (Hematoxylin and eosin, 
right). C: Invasive lobular carcinoma with gland formation (Hematoxylin and eosin, right and immunoperoxidase stain for E-
cadherin, left).World Journal of Surgical Oncology 2005, 3:73 http://www.wjso.com/content/3/1/73
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Case- 5
A 37 year-old woman presented with a left breast mass.
Stereotactic needle core biopsy revealed in-situ and inva-
sive, moderately differentiated carcinoma that was classi-
fied as ductal. Subsequent wide local excision of the mass
was performed.
Microscopic findings
The excisional biopsy revealed an invasive tumor measur-
ing 1.9 cm. The invasive carcinoma predominantly exhib-
ited a classical lobular pattern with well-formed glands
comprising 20% of the tumor. Extensive multifocal classi-
cal LCIS, focally florid type was also present. The tumor
was positive for estrogen and progesterone receptors by
immunohistochemistry. No membrane expression for
HER-2/neu was present.
There was no E-cadherin cell membrane reactivity in the
invasive component, both phenotypically lobular and
ductal areas (Figure 5) as well as in adjacent LCIS (Figure
5A).
Aberrant E-cadherin protein expression in this case con-
sisted of complete absence of immunoreactivity in an
invasive tumor with areas of unquestionable glandular
differentiation.
Discussion
E-cadherin is a transmembrane glycoprotein that medi-
ates calcium- dependent cell-cell adhesion and is
expressed mainly in epithelial cells and thought to play a
critical role in epithelial differentiation and morphogene-
sis [10,11]. Mutations in the E-cadherin gene (CDHI)
located on chromosome 16q22.1 have been demon-
strated in gastric, ovarian, endometrial and thyroid carci-
nomas in addition to lobular breast carcinomas [12].
More recently molecular alteration in the E-cadherin gene
resulting in loss of expression of E-cadherin in in situ and
invasive lobular carcinomas has been demonstrated by
molecular studies [12-16]. Somatic mutations in CDH1
occur in lobular breast carcinomas with a frequency rang-
ing from 10–56% (15–20% of invasive lobular carcino-
mas) and are rare in ductal carcinomas [17,18]. Molecular
alteration with loss of heterozygosity at 16q21.1 is the
most frequent chromosome alteration in lobular carci-
noma and correlates with the loss of E-cadherin expres-
sion [19]. In lobular carcinomas and diffuse type of gastric
carcinomas absence of E-cadherin expression has been
suggested to contribute to discohesive, single cell and
infiltrative growth characteristic of these tumors [20,21].
Several studies have demonstrated the reliability of E-cad-
herin as a marker for distinguishing ductal from lobular
carcinoma. In a study by Acs et al, where 183 invasive
(duct, lobular and mixed) and 198 in situ carcinomas
were studied, all in situ and invasive ductal carcinomas
showed strong membrane E-cadherin expression. Forty-
one of 42 invasive and 50 of 53 in situ lobular carcinoma
showed complete absence of E-cadherin expression [1].
Moll  et al, studied 89 primary infiltrating carcinomas
immunohistochemically using an antibody to E-cadherin
and found that 78% of well and moderately differentiated
invasive duct carcinomas (IDC) showed strong linear
staining for E-cadherin. Fifty-four percent of the poorly
differentiated IDC however, had reduced and heterogene-
ous staining. E-cadherin reactivity was absent in 86.4% of
the invasive lobular carcinomas and there was weak stain-
ing in 13.6 %. Among the in situ carcinomas the majority
of DCIS had strong E-cadherin expression and all cases of
LCIS showed absence of staining [7].
We have separately studied a series of 132 breast carcino-
mas, both in situ and invasive, for E-cadherin expression
[22]. In this series there was 100% correlation between
classification as ductal or lobular on the basis of conven-
tional histologic criteria and E-cadherin reactivity. In the
course of this study we observed some examples of in situ
lobular carcinoma involving ducts and lobules which
contained residual non-neoplastic E-cadherin positive
epithelial and myoepithelial cells. In some instances,
especially when there was pagetoid spread of LCIS, stain-
ing of non-neoplastic cells could be mistaken for reactivity
in the in situ carcinoma. We also have seen cases where in
situ lobular carcinoma displayed fragmented, discontinu-
ous and usually weak reactivity. These phenomena prob-
ably account for most of the reported instances of lobular
carcinoma with E-cadherin reactivity.
Few studies have specifically investigated invasive carcino-
mas with mixed duct and lobular features (IDLC). Acs et
al, investigated 41 cases which were classified as such due
to the presence of a "mixture in variable degrees of ductal
cytology and growth pattern (large, pleomorphic cells
with cohesive cellular arrangement with or without lumen
formation) and typical lobular pattern (dispersed infil-
trating fashion) in the same lesion, or to occasional
tubules or small nest formation in a lesion that otherwise
showed a typical lobular type of infiltration and cytology"
[1]. They correlated the E-cadherin immunohistochemical
staining patterns with morphologic features (presence/
absence of tumor cell nests and trabeculae, tubule/lumen
formation, intracytoplasmic lumina, discohesion) in
these cases and found three patterns of E-cadherin expres-
sion. Ten cases grouped as "lobular like" IDLC showed
similar absence of staining as seen in traditional invasive
lobular carcinomas while twenty-four "ductal like" IDLCs
had uniform membrane positivity similar to that seen in
typical ductal carcinomas. The accompanying in situ car-
cinoma was mainly LCIS and DCIS, respectively, in these
groups. A third group comprising the remaining 7 casesWorld Journal of Surgical Oncology 2005, 3:73 http://www.wjso.com/content/3/1/73
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deemed as the "intermediate" IDLC, demonstrated focal,
complete loss of E-cadherin staining. These tumors were
accompanied by LCIS and DCIS. Statistical analysis
showed that complete loss of immunostaining correlated
well with the histologic impression of lobular features
and lack of tubule or lumen formation exhibited by IDLC.
Acs et al concluded that all 10 "lobular like" and 24 "duc-
tal like" examples of infiltrating carcinomas demonstrated
E-cadherin expression similar to typical lobular and duc-
tal carcinomas, respectively, and therefore, could be fur-
ther classified based on their immunophenotype for E-
cadherin. However, 7 (3.8%) of 182 invasive carcinomas
in their study remained histologically and immuno phe-
notypically mixed ductal and lobular carcinoma [1].
These latter cases demonstrated real heterogeneity in E-
cadherin expression, however, the authors noted that
areas of tumor showing complete lack of membrane stain-
ing correlated well with the histologic impression of lob-
ular features exhibited by the tumor.
Goldstein et al, investigated 80 mixed (lobular and ductal)
breast carcinomas. They found that the percentage of
strongly E-cadherin-reactive lobular carcinoma cells was
greatest in the mixed, predominantly ductal carcinomas
and the greatest numbers of strongly E-cadherin-stained
lobular carcinoma cells were identified near the periphery
of the mixed carcinomas, particularly along the leading
edge of these tumors. In addition, they observed that the
nuclear grade of the lobular carcinoma component
increased as the percentage of the carcinoma that was of
the ductal type increased [9]. In the small series that we
studied [22], four carcinomas with duct and lobular fea-
tures were E-cadherin positive. These divergent results
indicate that further work needs to be done to determine
how E-cadherin immunostaining can be used for the clas-
sification of structurally heterogeneous tumors.
The cases described in the present study represent a phe-
nomenon wherein the histological structural phenotype
did not match the "genotype" as suggested by the staining
pattern of the E-cadherin immunohistochemical stain.
This "aberrant" staining pattern is exceedingly rare in our
experience. In cases 1, 2, 3, and 5 invasive carcinomas
with predominantly gland forming elements and there-
fore ductal phenotype lacked E-cadherin reactivity. The
differential diagnostic option in cases 1–3 and 5 is tubu-
lolobular carcinoma based on the hybrid morphology of
gland (tubules) and linear (lobular) growth pattern. Tub-
ulolobular carcinoma is a distinct subtype of mammary
carcinoma, which were originally thought to represent a
tubular variant of lobular carcinoma. Few studies have
examined the immunoprofile of tubulolobular carcinoma
with respect to the E-cadherin staining pattern. In a recent
study by Wheeler et al in which 27 cases of tubulolobular
carcinoma composed of intermixed, round to angulated
tubules and single file cell cords with diffuse and targetoid
growth pattern demonstrated strong and diffuse positivity
for E-cadherin in both the cell cord and tubular compo-
nents [23]. In our experience, mammary carcinomas with
duct and lobular features also showed E-cadherin positiv-
ity. The diffuse E-cadherin positive staining in tubulolob-
ular mammary carcinoma appears to support a ductal
differentiation rather than lobular origin However, in
cases 1–3 and 5 the E-cadherin immunostaining in the
glandular components was negative or weakly positive. In
the fourth case, the poorly differentiated invasive carci-
noma with pleomorphic lobular features exhibited an
unusual and heterogeneous pattern of E-cadherin expres-
sion. In addition to strong cell membrane positivity, there
was also cytoplasmic as well as membrane dot-like E-cad-
herin staining of tumor cells.
Cytoplasmic E-cadherin reactivity has been described in
diffuse type of gastric adenocarcinomas as well as in some
invasive lobular carcinomas [13,21,24]. Acs and co-work-
ers encountered a single case of E-cadherin-positive inva-
sive lobular carcinoma which was histologically
compatible with pleomorphic lobular carcinoma and
associated with intermediate grade solid DCIS. The
authors surmised that this tumor was most likely an
example of ductal carcinoma with a dispersed growth pat-
tern. In addition, peri-nuclear dot staining by E-cadherin
was seen in two cases of LCIS. Such aberrant staining may
be due to mutant E-cadherin, which is incorrectly proc-
essed within the Golgi apparatus, or from accelerated pro-
tein turnover [1]. Kowalski et al., reported that all eight
invasive lobular carcinomas showed only cytoplasmic
staining for E-cadherin which was also localized to the
cytoplasm in the majority of (7/9) metastatic lobular car-
cinomas [21]. In gastric examples, it has been suggested
that cytoplasmic localization was due to abnormal trans-
port mechanisms which were also present in the non-
malignant gastric epithelium. This observation was taken
to be evidence that alteration in E-cadherin occurs early in
the development of gastric carcinogenesis. This finding
was not observed in the non-neoplastic breast tissue [24].
Molecular studies have shown that invasive breast cancer
is a disease with multiple cytogenetic subclones which are
also present in the preinvasive lesions [25]. The two major
types of breast cancer exhibit genetic heterogeneity, but
occasionally a small percentage of DCIS cases are accom-
panied by invasive lobular carcinoma and similarly, LCIS
cases may develop invasive carcinoma of the ductal or
lobular type [26]. Transition from LCIS towards ductal
invasive carcinoma or from DCIS towards lobular inva-
sive carcinoma is possible [25]. Molecular analyses of
pure tubular carcinomas using comparative genomic
hybridization suggest that lobular and tubular carcinomas
share an early genomic change, with a similar mechanismWorld Journal of Surgical Oncology 2005, 3:73 http://www.wjso.com/content/3/1/73
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of progression [27]. The aberrant staining patterns
reported in this study may be due to non-functional E-
cadherin protein. Disruption of E-cadherin signaling with
inactivation of E-cadherin protein by phosphorylation by
activation of SRC family kinases and several growth factor
receptors has been previously reported. [28]. Normal E-
cadherin expression can be seen despite compromised
functional ability via defects in catenin (alpha, beta and
gamma) [29] Loss of E-cadherin expression can occur by
gene deletion, as well as defects in transcription and meth-
ylation [30]. E-cadherin gene transcription is inhibited by
two zinc-finger transcription factors SLUG and SNAIL,
which may cause transient down-regulation and up-regu-
lation of E-cadherin in primary and metastatic breast car-
cinoma [31].
We speculate that E-cadherin may play a critical role in
molecular classification of breast carcinoma and may fur-
ther elucidate the origin of tumors with a mixed or dis-
cordant phenotype.
Conclusion
Findings such as those illustrated in this study occur in vir-
tually all biologic phenomena and they do not invalidate
the very high degree of correlation between the expression
of E-cadherin and the classification of breast carcinomas
as ductal or lobular type on the basis of conventional his-
tologic criteria. Further studies are necessary to clarify
whether E-cadherin protein is non-functional or truly rep-
resents exceptional biology in breast carcinomas exhibit-
ing aberrant staining of E-cadherin.
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